Halozyme Therapeutics | Brutto Fortjeneste På Salg



Gross Profit On Sales Endring Dato
Acadia Pharmaceuticals USD 237.8M 72.86M 2024-12
Agios Pharmaceuticals USD 9.47M 1.29M 2024-12
Alnylam Pharmaceuticals USD 490.35M 75.33M 2024-12
Amarin USD 16.28M 26.49M 2024-09
Amgen USD 5.97B 781M 2024-12
Baxter International USD 1.02B 19M 2024-12
Cytokinetics -160545000 81.19M 2024-09
DBV Technologies -30442000 30.56M 2024-09
Eli Lilly USD 11.13B 1.86B 2024-12
Halozyme Therapeutics USD 255.95M 15.3M 2024-12
Indivior 248M 1000K 2024-09
Ionis Pharmaceuticals USD 222.75M 90M 2024-12
MannKind USD 59.17M 6.82M 2024-12
Pfizer USD 12.11B 718M 2024-12
United Therapeutics USD 660M 5.8M 2024-12



Halozyme Therapeutics Brutto Fortjeneste På Salg - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.